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Abstract  
The popularity of pericyte research is increasing, and this was not more evident than at the recent 
2019 Brain meeting in Yokohama which featured a large number of presentations focused on brain 
pericyte research, including the Presidential Symposium. In this article, we will provide a history 
of brain pericyte research, present the results of our analysis showing a substantial increase in brain 
pericyte research presented at Brain meetings since 2005, suggest reasons for their increased 
popularity, and comment on what the future holds for brain pericyte research.  
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History of Brain Pericyte Research  
Eberth and Rouget are often credited as the first authors to describe pericytes. Their 19th century 
publications included detailed anatomical drawings of cellular and vascular structures and 
physiological observations in which they identified contractile elements on capillaries displaying 
pericyte-like morphology.1, 2 The general history of pericyte research has been previously reported3  
but the initial observations of brain pericytes have not been extensively discussed. 
 
In 1923, German anatomist K.W. Zimmerman released his seminal work ‘Der feinere Bau der 
Blutcapillaren’, a culmination of 40 years worth of histological observations, including some of 
the first published literature on brain pericytes.4 Zimmerman mused on how to better describe 
Rouget cells, eventually naming them pericytes; referring to the tendency of pericytes to wrap 
around capillaries. 
 
Zimmerman observed that brain tissue was ‘…more strongly impregnated with pericytes’ 
compared to other major organs, and noted that brain vasculature contained smooth muscle fibres 
and precapillary transition forms all the way down to the microvasculature. Interestingly, 
Zimmerman describes endothelial veiling Rouget cells on the smallest arteries, which appear to 
have similar morphology to the mural cells with circumferential processes that wrap around the 
branching vessels off penetrating arterioles. While there remains controversy as to the exact 
naming of these transitional mural cells,5 these cells have been described as slightly more 
elongated than smooth muscle cells, enveloping the entire endothelium, and possessing protruding, 
ovoid cell bodies similar to those of pericytes.6 Grubb et al. propose further characterisation of 
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similar vascular structures as precapillary sphincters, important regulators of cerebral perfusion at 
the branch point off penetrating arterioles.7 Further down the vascular tree, Zimmerman describes 
cells seen in Fig. 1A-C as capillary pericytes, which in recent times have been described as mesh, 
thin strand or helical pericytes,6 and are similar to contemporary microscopy images of pericytes 
within the capillary bed (Fig. 1D-F).  
 
Zimmerman also observed intercapillary pericyte processes, also called pericyte bridges. 
Contemporary research has shown that in addition to forming connections with underlying 
endothelial cells, pericytes can span several endothelial cells, and occasionally connect with 
endothelial cells in neighbouring capillaries with fine processes that traverse the intercapillary 
space.8  Interestingly, this physiology seems to be mainly restricted to retinal,9 skeletal and cardiac 
muscle10 pericytes, with this phenomenon only recently reported in brain,11 and it is unclear to 
what extent they occur throughout the brain. The lack of these ‘bridges’ may reflect the collateral 
redundancy found in the cerebral vasculature.12 Zimmerman remarked that the endothelial tube is 
‘…poorly implanted in the brain and is difficult to generate usable sections for’,4 which may 
explain the initial lack of follow up on pericyte characterisation in the brain, alongside the 
difficulty in obtaining specific staining. 
 
The popularity of brain pericyte research is increasing 
Interest in brain pericytes remained low over the next 50 years until advances in electron 
microscopy allowed researchers to better characterise the cellular makeup of the brain. In early 
1970, King and Schwyn observed squirrel monkey brain sections via electron microscopy,13 
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concluding that pericytes are truly perivascular and easily identified by the vascular basal lamina 
which encompasses the cell body and processes. Another early study in the cat brain demonstrated 
that pericytes could be released from the basement membrane of the capillary and transform into 
microglia, which required the assistance of astrocytic endfeet,14 showing the dynamic roles of these 
cells. Interest in brain pericytes steadily increased during the 1970s and 80s, with a key word 
analysis of the NCBI database revealing just under five hundred publications that included brain 
and pericyte in their keywords or title between the years 1970 and 2000.15 However, only 20% of 
those publications included brain, pericyte and disease. In the 20 years following, from 2001 to 
early 2020, pericyte research has exploded with almost two thousand publications including brain 
and pericyte, while almost 50% of those publications included brain, pericyte and disease. The 
increase in interest regarding pericytes in the brain during disease highlights our growing 
understanding of how pericyte and vascular dysfunction can underly and exacerbate many disease 
processes, including common neurological disorders such as stroke16 and Alzheimer’s Disease.17 
 
This rise in interest in brain pericytes culminated in them being the topic of Professor David 
Atwell’s Presidential Symposium at the recent Brain 2019 meeting in Yokohama Japan. During 
his talk Professor Atwell presented recent results on the role of pericytes in neurovascular coupling 
and cerebral blood flow (CBF) deficits following cerebral ischemia18 and Alzheimer’s disease 
(AD).19 He concluded by imploring the audience of the importance of these cells that had been 
relatively neglected for over 100 years and to research them. While attending the Brain 2019 
meeting, we noticed the large number of oral and poster presentations as well as a dedicated 
symposium specifically focusing on brain pericytes.  
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In order to confirm this increase in pericyte interest, we conducted an analysis of the number of 
abstracts presenting on brain pericytes in Brain meetings since 2005. All abstracts were freely 
available through meeting supplements published by the Journal of Cerebral Blood Flow and 
Metabolism. We included abstracts for all Brain symposia, oral and poster abstracts and 
unclassified late breaking abstracts. We excluded all Brain PET abstracts and educational course 
abstracts. We discovered a 10-fold increase in the number of abstracts presenting on brain pericytes 
between 2005 and 2019, increasing from 0.4% (n = 3) of all abstracts in 2005 to 4% (n = 29) of all 
abstracts in 2019 (Fig. 2A-B). Interestingly, there was a noticeable jump in the number of abstracts 
presenting on brain pericytes at the Brain meeting held in Vancouver in 2015, increasing from 1% 
of all abstracts in 2013 to 3% of all abstracts in 2015 (Fig. 2A-B). The distribution of different 
topic categories of pericyte abstracts is presented in Fig. 2C. This graph shows that earlier abstracts 
(2005, 2007) presented predominantly on the anatomy and signalling (e.g. calcium signalling) of 
pericytes, whereas from 2009 onward abstracts were predominantly presenting on the role of 
pericytes in ischemia, CBF regulation and BBB regulation. This rise in interest has led to some 
important paradigm-shifting discoveries about the critical roles of pericytes in brain function in 
both health and disease.  
 
Functions of pericytes in the healthy and diseased brain  
The rise in brain pericyte research could be attributed to the importance of these cells for numerous 
brain functions that have only become apparent recently, and our improved accuracy and 
reproducibility to investigate them through imaging and cell specific transgenic mouse 
technologies. Three of the major roles that pericytes play in the brain, amongst others,15 are the 
regulation of CBF, the maintenance of the blood-brain barrier (BBB) and the regulation of immune 
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function. In this section, we will briefly discuss some of the associated key publications that 
revealed these discoveries. 
 
Regulation of cerebral blood flow in health  
Early work by Peppiatt et al.20 showed that electrical stimulation led to constrictions of capillaries 
at pericyte locations in the retina, while treatment with glutamate to simulate neuronal activation 
led to dilation of capillaries at pericyte locations.  Hall et al.18 replicated these findings in vivo by 
showing somatosensory stimulation evoked capillary dilations at pericyte locations, which 
preceded the dilation of the parent arteriole. This challenged the long-held understanding that 
dilation of the penetrating arteriole by VSMCs was the main stimulus for increased blood flow in 
response to neuronal activation and that capillary dilation occurs passively in response to increases 
in upstream flow.  
 
Detailed investigation of the relationship between the arteriole dilation induced by VSMCs and 
capillary dilation by pericytes by Hill et al.21 revealed that capillary diameter did not change at 
pericyte locations in response to somatosensory stimuli, and that arteriole dilation by VSMCs was 
responsible for increased blood flow. Pericytes, in this paper, were defined as alpha-smooth muscle 
actin (αSMA) negative cells. Any αSMA-positive cells with circumferential processes were 
defined as VSMCs despite their discontinuous appearance that is inconsistent with the classical 
notion of arteriolar VSMCs and more consistent with the morphology of a pericyte.5, 22  
 
Consensus appears to be emerging that regardless of nomenclature, the primary site of CBF 
regulation is at small vessels covered by spatially separate, αSMA-positive contractile mural cells. 
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This is reflected in four recent publications. Firstly, Rungta et al.23 systematically analyzed the 
response of the entire vascular tree from the pial arteries to capillaries, and identified the primary 
functional unit that dilated first, in response to odor, was the arteriole and its branching first-order 
capillary, with VSMCs and pericytes respectively controlling these responses. Kisler et al.24 
showed that pericyte deficient mice have reduced capillary CBF responses to evoked stimuli 
(neurovascular uncoupling) leading to reduced oxygen supply and metabolic stress. 
Nikolakopoulou et al.25  showed that inducible pericyte knockdown in adult mice resulted in basal 
CBF deficiency and BBB disruption. Grubb et al.26 report that sphincters at the transition between 
penetrating arteriole and first order capillary are encircled by contractile mural cells that could not 
be definitively defined as pericytes or VSMCs, and that these sphincters dilate in response to 
somatosensory stimuli. Finally, Nelson et al.27 specifically induced the expression of 
channelrhodopsin-2 (ChR2) in pericytes in aged mice and showed that excitation of ChR2 with 
488nm light caused contraction of brain capillary pericytes and a subsequent 8% reduction in 
capillary diameter which led to a 42% reduction in red blood cell velocity. This study further 
demonstrates that pericytes are contractile cells that can regulate capillary diameter and CBF.  
 
Regulation of cerebral blood flow in disease 
 
Capillary diameters are small enough to require blood cell deformation during passage meaning 
the effects of dilation or constriction on capillary flow are not accurately estimated by Poiseuille’s 
law and actually exceed the r4 effect of vessel radius on flow.28 Therefore pericyte constriction of 
capillaries may also be an important therapeutic target in neurological diseases where CBF is 
compromised. Yemisci et al.29 reported pericyte constriction of capillaries at 6 hours of reperfusion 
following 2-hour middle cerebral artery occlusion (MCAo), but did not report pericyte cell death 
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in vivo. Hall et al.18 reported that pericytes die at 24 hours after 90 minutes of experimental MCAo 
but did not investigate pericyte constriction in vivo. Interestingly, Hill et al.21 provided some of the 
most convincing evidence of capillary constrictions at 4 hours post MCAo, however, the authors 
attributed these constrictions to VSMCs despite the convention being to classify these cells as 
pericytes.5 In addition to brain ischemia, Nortley et al.19 reported capillaries being constricted 
specifically at pericyte locations, but not arterioles and venules in humans developing Alzheimer’s 
Disease (AD) and in a mouse model of AD. This suggests that the reduction of CBF known to 
occur in AD30 is produced by capillaries rather than by arterioles.  
 
 
Regulation of Blood-Brain Barrier in health  
 
The BBB is located at the capillary endothelial cells of the brain, which creates a physical and 
chemical barrier to maintain tight control of the extracellular environment of the CNS.31 Although 
astrocytes and the extracellular matrix have been known to contribute to barrier function for some 
time,31 it has only been in the last 10 years that the role of pericytes to barrier function and 
dysfunction has begun to emerge.  
 
Three papers published in 2010 first revealed the key role that pericytes play in BBB function and 
development. These studies cleverly used mutations or deletions to disrupt platelet-derived growth 
factor (PDGF)-B/PDGF receptor β (PDGFRβ) signalling in mice which resulted in pericyte loss 
and provides a useful tool to assess pericyte function. Armulik et al.32 showed that Pdgfbret/ret mice, 
with only 26% pericyte coverage of the vasculature compared to control levels, have increased 
permeability to water and low molecular weight markers via increased endothelial cell 
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transcytosis. They also showed that pericytes reduce barrier permeability via regulating endothelial 
cell gene expression and inducing polarization of astrocyte endfeet. Research by Bell et al.33 
extended these findings by demonstrating that a loss of pericytes in Pdgfrβ+/- mice led to an 
increased accumulation of serum and neurotoxic macromolecules, which preceded neuronal 
degenerative changes. Similarly, Daneman et al.34 showed using both null and hypomorph Pdgfrβ 
mice, that pericytes are critical for BBB formation, the coverage of capillaries by pericytes can 
determine vascular permeability, and pericytes can regulate tight junction formation between 
endothelial cells. More recent work by Berthiaume et al.35 revealed that a sudden loss of a single 
pericyte by laser ablation could be compensated for by extension of processes from adjacent 
pericytes to contact uncovered regions.  Interestingly, the uncovered regions of capillaries had 
normal barrier function but were dilated until adjacent pericyte processes covered the region. 
Taken together these studies suggest that pericytes play a critical role in the development and 
maintenance of the BBB, they may be structurally plastic in vivo and able to compensate for an 
acute loss of pericyte coverage, while a chronic loss of pericytes leads to pathology.  
 
Regulation of Blood-Brain Barrier in disease 
BBB disruption and release of toxic blood molecules into the brain as well as vasogenic edema 
contributes to neuronal injury and patient deterioration following stroke.36 While previous work 
highlighted that pericytes maintain the barrier to protect the normal brain, Underly et al.37 showed 
that photothrombotic occlusion of cerebral capillaries resulted in matrix metalloproteinase 
activation at pericyte somata that was followed by localized plasma leakage. These results suggest 
that pericytes are responsible for a rapid and localized proteolytic cleavage of the BBB and may 
be a potential therapeutic target to reduce BBB disruption following stroke.  
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In addition to stroke, AD is also characterized by an impaired BBB. Work by Sengillo et al.38 
showed that pericyte number in the cortex and hippocampus of AD patients are reduced by 59% 
and 60% respectively, and this was correlated with BBB disruption. Mechanistic studies carried 
out by the same group showed that overexpression of APP alone or PDGFR-β deficiency alone in 
mice was not enough to aggravate AD pathology.39 However, the combination of APP over-
expression and PDGFR-β deficiency had a synergistic effect on accelerating AD pathology. This 
pericyte loss led to reduced Beta-amyloid (Aβ) clearance by pericytes and subsequent Aβ 
accumulation, which in turn amplifies the loss of pericytes leading to increased BBB damage and 
neuronal degeneration.39 This suggests pericytes play an integral role at multiple sites of the AD 
cascade and may be an important therapeutic target for the treatment of AD.  
 
Regulation of immune function  
The location of pericytes at the interface between the brain and its vasculature place them in an 
ideal position to regulate immune trafficking and function within the brain. Brain pericytes in vitro 
were shown to be sensitive to tumor necrosis factor alpha (TNF-α), a pro-inflammatory cytokine, 
by stimulating the release of matrix metalloproteinase-9 (MMP-9) altering BBB permeability and 
therefore leukocyte trafficking.40 This was supported by the finding that pericytes regulated the 
transmigration of neutrophils across the BBB via their expression of interleukin-8.41 Further 
investigation showed that brain pericytes had a strong immune activation of chemokines, cytokines 
and cellular adhesion molecules in response to pro-inflammatory challenges such as TNFα, 
interleukin-1β, lipopolysaccharide42 and transforming growth factor beta-1.43 A more recent study 
reported in vivo evidence that brain pericytes acted as the initial sensors of external insults through 
secretion of the chemokine CCL2, which increased synaptic transmission of glutamatergic 
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neurons.44 Another postulated neuroinflammatory role for brain pericytes is phagocytosis. In the 
context of AD, pericytes are able to phagocytose and clear amyloid beta 40 (Aβ40) through a low-
density lipoprotein receptor-related protein 1 (LRP-1)-dependent mechanism.39 Likewise 
following ischemic stroke, brain pericytes acquired a microglial phenotype that assisted in the 
clearance of cellular debris in the lesioned area.45 Therefore, pericytes have multiple roles in 
immune regulation in the brain which could be implicated in numerous neurological diseases. 
 
The future of pericyte research  
Attempts to modulate pericyte function in neurological diseases have already begun. 
Administration of adenosine packaged into nanoparticles as well as the blood brain barrier 
impermeable S- tert-butyl-α-phenylnitrone can maintain capillary diameters after ischemia and 
reperfusion without leaving the vascular compartment, which strongly suggests a therapeutic effect 
on cells of the neurovascular unit (the anatomical and functional structure linking the brain 
parenchyma to the vasculature composed of the following cell types: neurons, astrocytes, 
endothelial cells, pericytes and vascular smooth muscle cells),46 however the role of pericytes in 
the effect was not specifically investigated.47, 48 As well as repurposing existing drugs, the recent 
development of a commercially available system that allows real time in vitro assessment of brain 
pericyte contractility has opened up new avenues for high-throughput screening for novel 
compounds that can slow down or prevent pericyte constriction to ischemia.49  Novel compounds 
that promote pericyte relaxation or prevent pericyte contraction identified by in vitro screening can 
progress to proof of principle screening for in vivo activity in animal models of stroke. However, 
due to healthy pericytes in non-disease areas of the brain and body, as well as potential systemic 
off target effects of pharmaceutical compounds, specific targeting is imperative, for example by 
packaging of therapeutic compounds into brain pericyte-targeted antibody-coated nanoparticles. 
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Although there are a number of fully characterised and biocompatible nanoparticle carriers (see 
Landowski et al.50 for review), there is a lack of unique cell surface markers for pericytes meaning 
that directing these nanoparticle carriers specifically to brain pericytes is not currently possible.  
 
Brain pericytes have previously been identified in vivo by the expression of platelet derived growth 
factor receptor beta (PDGFRβ), Desmin, NG2 or αSMA in combination with their perivascular 
location, their discontinuous cellular processes and protruding nucleus.5, 22 However, use of these 
markers in isolation as a means of specifically targeting therapeutics to brain pericytes may not be 
viable as these markers are also expressed by VSMCs,51 perivascular fibroblasts52 and 
oligodendrocyte precursor cells.53 Recent advances in single cell RNA sequencing analysis 
combined with immunofluorescence and morphological analysis has identified abcc9 
(Sulfonylurea Receptor 2) and kcnj8 (Potassium Inwardly Rectifying Channel Subfamily J 
Member 8) as specific brain capillary pericyte markers.51 However, the expression of these 
markers in neurological disease states has not yet been investigated.  
 
Pericyte targeting may be complicated by potential changes in the expression profile of pericyte 
markers in disease. Human brain pericytes, but not VSMCs, shed soluble PDGFRβ in culture 
media, which is increased by hypoxia.54 Increased soluble PDGFRβ in the CSF is a biomarker of 
BBB disruption in humans with early cognitive dysfunction, indicative of pericyte injury.55, 56 
Identification of healthy and disease specific pericyte markers will provide a better understanding 
of the phenotype and function of pericytes in vivo as well as pave the way for the development of 
small chemical molecules, DNA, or antibodies, exploiting an overexpressed marker on the pericyte 
cellular membrane, that can be used for targeted delivery of therapeutics.   
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Conclusion 
Our understanding of brain pericyte biology has expanded exponentially over the last 15 years. 
This research highlights that pericytes are multi-functional cells that are embedded in the 
neurovascular unit that can respond to signals from cells in the brain and the vasculature. Targeted 
modulation of pericyte function/dysfunction may open up novel therapeutic options for a number 
of neurological diseases.  
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Figure Legends 
 
Figure 1. Comparison of Zimmerman’s sketches of brain pericytes with contemporary 
confocal fluorescent images of brain pericytes. A-C) Zimmerman’s sketches of cat cerebellum 
capillary pericytes, one of the first known sketches of brain pericytes, reproduced with permission 
from Fig. 180, 181 and 182 in his 1923 publication. Young cat, cerebellar capillary pericytes with 
broad primary processes. A) and C) each show an intercapillary process or ‘pericyte bridge’. D-F) 
Scanning confocal fluorescent images of cortical pericytes in NG2-DsRed mice (red) associated 
with FITC-albumin-positive (green) capillary lumens (Brown L.S.). Scale bar = 20μm. 
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Figure 2. Pericyte abstracts presented at Brain meetings from 2005 to 2019. A) Number of 
pericyte abstracts as a percentage of total abstracts. B) Absolute number of pericyte abstracts. C) 
Topic categories of pericytes abstracts as a percentage of total abstracts. AD = Alzheimer’s 
Disease, CBF = cerebral blood flow regulation, BBB = blood brain barrier, Other = Diseases other 
than ischemia or AD, e.g. diabetes, Huntington’s disease, glioma, traumatic brain injury and 
multiple sclerosis. Some abstracts presented on a disease and another category, e.g. ischemia and 
CBF. In these cases, the disease took precedence and that was the category the abstract was 
assigned.  
 
 
 
 
 
